Financial burden of household out-of-pocket expenditures for prescription drugs: Cross-sectional analysis based on national survey data

Open Medicine

Volumn 5, Issue 1, 2011, Pages 1-9

  McLeod, Logan ^a   Bereza, Basil G ^b   Shim, Minsup ^b   Grootendorst, Paul ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ARTICLE; BUDGET; CANADA; CONFIDENCE INTERVAL; COST OF ILLNESS; CROSS-SECTIONAL STUDY; ECONOMICS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; INFORMATION PROCESSING; INSURANCE; STATISTICS;

BUDGETS; CONFIDENCE INTERVALS; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; HEALTH EXPENDITURES; HEALTH POLICY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; ONTARIO; PRESCRIPTION DRUGS;

EID: 79251560043     PISSN: None     EISSN: 19112092     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Demers V, Melo M, Jackevicius C, Cox J, Kalavrouziotis D, Rinfret S, et al. Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures. CMAJ 2008;178:405-409.
2. Grootendorst P. Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessment. Can J Clin Pharmacol 2002;9:79-99.
3. Grootendorst P, Palfrey D, Willison D, Hurley J. A review of the comprehensiveness of provincial drug coverage for Canadian seniors. Can J Aging 2003;22:33-44.
4. Ungar WJ, Witkos M. Public drug plan coverage for children across Canada: a portrait of too many colours. Healthc Policy 2005;1(1):100-122.
5. Kapur V, Basu K. Drug coverage in Canada: Who is at risk? Health Policy 2005;71:181-193.
6. 2011, Drug expenses coverage in the Canadian population: protection from severe drug expenses. Toronto: Fraser Group/Tristat Resources; 2002. Available from: http://www.frasergroup.com/downloads/severe_drug_e.pdf (accessed 2010 Mar 2).
7. Coombes ME, Morgan SG, Barer ML, Pagliccia N. Who's the fairest of them all? Which provincial pharmacare model would best protect Canadians against catastrophic drug costs? Healthc Q 2004;7(4 Suppl):13-19.
8. Menon D, Stafinski T, Stuart G. Access to drugs for cancer: Does where you live matter? Can J Public Health 2005;96(6):454-458.
9. Anis AH, Guh D, Wang XH. A dog's breakfast: prescription drug coverage varies widely across Canada. Med Care 2001;39(4):315-326.
10. Grégoire JP, MacNeil P, Skilton K, Moisan J, Menon D, Jacobs P, et al. Interprovincial variation in government drug formularies. Can J Public Health 2001;92(4):307-312.
11. MacDonald K, Potvin K. Interprovincial variation in access to publicly funded pharmaceuticals: a review based on the WHO anatomical therapeutic chemical classification system. Can Pharm J 2004;137(7):29-34.
12. Morgan S, Hanley G, Raymond C, Blais R. Breadth, depth and agreement among provincial formularies in Canada. Healthc Policy 2009;4(4):e162-e184.
13. Canadian Institute of Health Information. How Common Are the Provincial/Territorial Public Drug Formularies? National Prescription Drug Utilization Information System (NPDUIS) Formulary Bulletin 2005:1-13.
14. O'Sullivan JF. Premium free in New Brunswick? [Internet]. CMAJ 2008 February 12. Available from:www.cmaj.ca/cgi/eletters/178/4/405#18695 (accessed 2010 May 13).
15. Boadway RF, Bruce N. Welfare economics. New York: Basil Blackwell Inc.; 1984.
16. User guide for the public-use microdata file-Survey of Household Spending, 2006. Ottawa: Statistics Canada; 2008. Cat. no. 62M0004XCB.
17. Alan S, Crossley TF, Grootendorst P, Veall MR. Distributional effects of 'general population' prescription drug programs in Canada. Can J Econ 2005;38:128-148.
18. Li Q, Racine JS. Nonparametric estimation of conditional CDF and quantile functions with mixed categorical and continuous data. J Bus Econ Stat 2008;26:423-434.
19. Cancer drug access for Canadians [Internet]. Toronto: Canadian Cancer Society; 2002. (accessed 2010 May 13). Available from: http://www.cancer.ca/canada-wide/about%20us/media%20centre/cw-media%20releases/cw-2009/~/media/CCS/Canada%20wide/Files%20List/English%20files%20heading/pdf%20not%20in%20publications%20section/CANCER%20DRUG%20ACCESS%20FINAL%20-%20English.ashx.
20. Federal/Provincial/Territorial Ministerial Task Force on the National Pharmaceuticals Strategy. National Pharmaceuticals Strategy: Progress Report [Internet]. Available from: http://www.hc-sc.gc.ca/hcs-sss/pubs/pharma/2006-nps-snpp/index-eng.php (accessed 2010 June 16).